Yet another quarter of very impressive top line growth but bottom line degrowth
I have been observing the results of a lot of companies. One common thing I observed is that, very poor top line growth. but very good bottom line growth. ( operating leverage, cost cutting whatever you call it). But astral is just the opposite.
Posts in category Value Pickr
Astral polytechnik ltd (05-11-2015)
Lincoln Pharma … the next mid-cap pharma in the making …? (05-11-2015)
I am just pointing out to the data that you have posted... Don't take it offensive... When we are putting data in public domain, we have to be careful... That's it... No comments on the stock or its performance or your comments... Hope you understand...
Automated Stock Analyzer (05-11-2015)
Sorry. I am pretty sure - checked a couple of stocks before responding. Has nothing to do with closing and opening. The VBA error is a sign that the site is not opening via Excel. Seen that in other users.
Automated Stock Analyzer (05-11-2015)
I had to close thrice and restart.. Pl try the full cycle and check
Automated Stock Analyzer (05-11-2015)
Works fine for me. Not a problem with Excel. Could be a firewall issue if done from work.
Abbott India: MNC pharma play on increased consumer spending (05-11-2015)
Positives
Look at the stock price of Abbott USA, shows a consistent rising trend with some slowdown in the last year. This indicates that they’re doing something right over there. Related link: http://www.bloomberg.com/news/articles/2015-11-05/meet-the-world-s-most-confident-consumers-flush-with-credit
Look at the products that they’ve launched. Ask a person who uses Pediasure… They’ll tell you that they buy it irrespective of the price.
Government spending in preventive healthcare has increased a lot in the past 2-3 years
A doctor who knows about Preventive & Social medicine says that major posts in rural government missions are being filled by PSM doctors
Connecting the dots backward indicate that they’re a consumer focused company
Nutritional product buyers love the brand they buy and are willing to pay the price
Promoters hold a major stake indicating they want control over how they invest going forward
Concerns
Privately held subsidiaries of the parent company operating in India
Sarla Performance Fibres – Another Interesting Textile Story in Making? (05-11-2015)
I am using the Nylon 66 thread now and let me tell you, there is no one who cam make ropes like the ones made by Sarla Flex in the US. There are top quality and as their usage in human life goes up, so shall the stock price, they have just started the US thing and at 59 I took a sizeable position. I am expecting that after these umbers posted in Nov 15, the company can do wonders over the next few quarters till 2020 if it goes to 100% capacity in US too.
Prashanth Jain and Kenneth Andrade have a positive view on this too, just a matter of time before they get in.
Lincoln Pharma … the next mid-cap pharma in the making …? (05-11-2015)
@ansii77 heyy....stake doesn't matter. My question is on the operation of the subsidiary where PAT margin is too low to be believed. Chances of cash being taken out is high in this scenario.
While I noted ur point on the stake.